No association of LOXL1 gene polymorphisms with Alzheimer's disease

NeuroMolecular Medicine

Volumn 13, Issue 2, 2011, Pages 160-166

  Abramsson, Alexandra ^a   Landgren, Sara ^a   Zetterberg, Madeleine ^a   Palmer, Mona Seibt ^a   Minthon, Lennart ^b   Gustafson, Deborah R ^a   Skoog, Ingmar ^a   Blennow, Kaj ^a   Zetterberg, Henrik ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Alzheimer's disease; Haplotype; LOXL1; Lysyl oxidase like 1; SNP

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; ARGININE; ASPARTIC ACID; GLYCINE; LEUCINE; LYSYL OXIDASE LIKE 1; OXIDOREDUCTASE; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA POLYMORPHISM; EXFOLIATION SYNDROME; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CROSS LINKING; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACID OXIDOREDUCTASES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 80051545114     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-011-8144-z     Document Type: Article

References (58)

1. Altman, D. G. (1991). Practical statistics for medical research (1st ed.). London: Chapman & Hall.
2. Aragon-Martin, J. A., Ritch, R., Liebmann, J., O'Brien, C., Blaaow, K., Mercieca, F., et al. (2008). Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma. Molecular vision, 14, 533-541. (Pubitemid 351472358)
3. Bayer, A. U., Ferrari, F., & Erb, C. (2002a). High occurrence rate of glaucoma among patients with Alzheimer's disease. European Neurology, 47, 165-168. (Pubitemid 34253039)
4. Bayer, A. U., Keller, O. N., Ferrari, F., & Maag, K. P. (2002b). Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. American Journal of Ophthalmology, 133, 135-137. (Pubitemid 34076513)
5. Berisha, F., Feke, G. T., Trempe, C. L., McMeel, J. W., & Schepens, C. L. (2007). Retinal abnormalities in early Alzheimer's disease. Investigative ophthalmology and visual science, 48, 2285-2289. (Pubitemid 351261307)
6. Blennow, K., Wallin, A., Agren, H., Spenger, C., Siegfried, J., & Vanmechelen, E. (1995). Tau protein in cerebrospinal fluid: A biochemical marker for axonal degeneration in Alzheimer disease? Molecular and Chemical Neuropathology, 26, 231-245. (Pubitemid 26002016)
7. Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010). Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Natural Reviews Neurology, 6, 131-144.
8. Boros, S., Kamps, B., Wunderink, L., de Bruijn, W., de Jong, W. W., & Boelens, W. C. (2004). Transglutaminase catalyzes differential crosslinking of small heat shock proteins and amyloid-beta. FEBS Letters, 576, 57-62. (Pubitemid 39330457)
9. Calabrese, M. F., & Miranker, A. D. (2009). Metal binding sheds light on mechanisms of amyloid assembly. Prion, 3, 1-4.
10. Challa, P., Schmidt, S., Liu, Y., Qin, X., Vann, R. R., Gonzalez, P., et al. (2008). Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma. Molecular vision, 14, 146-149. (Pubitemid 351193745)
11. Chen, L., Jia, L., Wang, N., Tang, G., Zhang, C., Fan, S., et al. (2009). Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population. Molecular vision, 15, 2349-2357.
12. Chen, H., Chen, L. J., Zhang, M., Gong, W., Tam, P. O., Lam, D. S., et al. (2010). Ethnicity-based subgroup meta-analysis of the association of LOXL1 polymorphisms with glaucoma. Molecular vision, 16, 167-177.
13. Come, J. H., Fraser, P. E,. & Lansbury, P. T., Jr. (1993). A kinetic model for amyloid formation in the prion diseases: Importance of seeding. In Proceedings of the National Academy of Sciences of the United States of America (Vol. 90, pp. 5959-5963). (Pubitemid 23191433)
14. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (New York, N. Y), 261, 921-923. (Pubitemid 23275809)
15. Estermann, S., Daepp, G. C., Cattapan-Ludewig, K., Berkhoff, M., Frueh, B. E., & Goldblum, D. (2006). Effect of oral donepezil on Intraocular pressure in normotensive Alzheimer patients. Journal of ocular pharmacology Therapeutics, 22, 62-67. (Pubitemid 43364082)
16. Excoffier, L., & Slatkin, M. (1995). Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Molecular Biology and Evolution, 12, 921-927.
17. Fan, B. J., Pasquale, L., Grosskreutz, C. L., Rhee, D., Chen, T., DeAngelis, M. M., et al. (2008). DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a US clinic-based population with broad ethnic diversity. BMC medical genetics, 9, 5.
18. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
19. Fuse, N., Miyazawa, A., Nakazawa, T., Mengkegale, M., Otomo, T., & Nishida, K. (2008). Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese. Molecular vision, 14, 1338-1343.
20. Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006). Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study. Lancet Neurology, 5, 228-234. (Pubitemid 43238346)
21. Hayashi, K., Fong, K. S., Mercier, F., Boyd, C. D., Csiszar, K., & Hayashi, M. (2004). Comparative immunocytochemical localization of lysyl oxidase (LOX) and the lysyl oxidase-like (LOXL) proteins: Changes in the expression of LOXL during development and growth of mouse tissues. Journal of Molecular Histology, 35, 845-855. (Pubitemid 41404631)
22. Hayashi, H., Gotoh, N., Ueda, Y., Nakanishi, H., & Yoshimura, N. (2008). Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population. American Journal of Ophthalmology, 145, 582-585.
23. Hulstaert, F., Blennow, K., Ivanoiu, A., Schoonderwaldt, H. C., Riemenschneider, M., De Deyn, P. P., et al. (1999). Improved discrimination of AD patients using beta-amyloid (1-42) and tau levels in CSF. Neurology, 52, 1555-1562. (Pubitemid 29220627)
24. Kagan, H. M. (1994). Lysyl oxidase: Mechanism, regulation and relationship to liver fibrosis. Pathology, Research and Practice, 190, 910-919. (Pubitemid 24370102)
25. Kessing, L. V., Lopez, A. G., Andersen, P. K., & Kessing, S. V. (2007). No increased risk of developing Alzheimer disease in patients with glaucoma. Journal of Glaucoma, 16, 47-51. (Pubitemid 46114773)
26. Kirby, E., Bandelow, S., & Hogervorst, E. (2010). Visual Impairment in Alzheimer's Disease: A critical review. Journal of Alzheimers Disease, 21, 15-34.
27. Kitamura, A., & Kubota, H. (2010). Amyloid oligomers: Dynamics and toxicity in the cytosol and nucleus. FEBS Journals, 277, 1369-1379.
28. Lee, K. Y., Ho, S. L., Thalamuthu, A., Venkatraman, A., Venkataraman, D., Pek, D. C., et al. (2009). Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese. Molecular vision, 15, 1120-1126.
29. Lemmela, S., Forsman, E., Onkamo, P., Nurmi, H., Laivuori, H., Kivela, T., et al. (2009). Association of LOXL1 gene with Finnish exfoliation syndrome patients. Journal of Human Genetics, 54, 289-297.
30. Linner, E., Popovic, V., Gottfries, C. G., Jonsson, M., Sjogren, M., & Wallin, A. (2001). The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type. Acta Ophthalmologica Scandinavica, 79, 283-285. (Pubitemid 32577314)
31. Liu, X., Zhao, Y., Pawlyk, B., Damaser, M., & Li, T. (2006). Failure of elastic fiber homeostasis leads to pelvic floor disorders. The American journal of pathology, 168, 519-528. (Pubitemid 43271150)
32. Livak, K. J. (1999). Allelic discrimination using fluorogenic probes and the 50 nuclease assay. Genetic Analysis, 14, 143-149. (Pubitemid 29095371)
33. Mabuchi, F., Tang, S., Ando, D., Yamakita, M., Wang, J., Kashiwagi, K., et al. (2005). The apolipoprotein E gene polymorphism is associated with open angle glaucoma in the Japanese population. Molecular vision, 11, 609-612. (Pubitemid 41410214)
34. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's Disease. Neurology, 34, 939-944. (Pubitemid 14076461)
35. Mitchell, P., Wang, J. J., & Smith, W. (1997). Association of pseudoexfoliation syndrome with increased vascular risk. American Journal of Ophthalmology, 124, 685-687. (Pubitemid 27469246)
36. Mori, K., Imai, K., Matsuda, A., Ikeda, Y., Naruse, S., Hitora-Takeshita, H., et al. (2008). LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population. Molecular vision, 14, 1037-1040. (Pubitemid 351843800)
37. Mossbock, G., Renner, W., Faschinger, C., Schmut, O., Wedrich, A., & Weger, M. (2008). Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population. Molecular vision, 14, 857-861. (Pubitemid 351699495)
38. Ovodenko, B., Rostagno, A., Neubert, T. A., Shetty, V., Thomas, S., Yang, A., et al. (2007). Proteomic analysis of exfoliation deposits. Investigative ophthalmology and visual science, 48, 1447-1457. (Pubitemid 351261324)
39. Ozaki, M., Lee, K. Y., Vithana, E. N., Yong, V. H., Thalamuthu, A., Mizoguchi, T., et al. (2008). Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese. Investigative ophthalmology and visual science, 49, 3976-3980.
40. Parisi, V., Miglior, S., Manni, G., Centofanti, M., & Bucci, M. G. (2006). Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma. Ophthalmology, 113, 216-228. (Pubitemid 43170770)
41. Pasutto, F., Krumbiegel, M., Mardin, C. Y., Paoli, D., Lammer, R., Weber, B. H., et al. (2008). Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Investigative ophthalmology and visual science, 49, 1459-1463.
42. Pinnell, S. R, & Martin, G. R. (1968). The cross-linking of collagen and elastin: Enzymatic conversion of lysine in peptide linkage to alpha-aminoadipic-delta-semialdehyde (allysine) by an extract from bone. In Proceedings of the National Academy of Sciences of the United States of America (Vol. 61 pp. 708-716).
43. Ramprasad, V. L., George, R., Soumittra, N., Sharmila, F., Vijaya, L., & Kumaramanickavel, G. (2008). Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India. Molecular vision, 14, 318-322. (Pubitemid 351279917)
44. Resnikoff, S., Pascolini, D., Etya'ale, D., Kocur, I., Pararajasegaram, R., Pokharel, G. P., et al. (2004). Global data on visual impairment in the year 2002. Bulletin of the World Health Organization, 82, 844-851. (Pubitemid 39573742)
45. Ressiniotis, T., Griffiths, P. G., Birch, M., Keers, S. M., & Chinnery, P. F. (2004). Apolipoprotein E promoter polymorphisms do not have a major influence on the risk of developing primary open angle glaucoma. Molecular vision, 10, 805-807. (Pubitemid 41358214)
46. Sakono, M., & Zako, T. (2010). Amyloid oligomers: Formation and toxicity of Abeta oligomers. FEBS Journal, 277, 1348-1358.
47. Sharma, S., Chataway, T., Burdon, K. P., Jonavicius, L., Klebe, S., Hewitt, A. W., et al. (2009). Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry. Experimental Eye Research, 89, 479-485.
48. Smith, D. G., Cappai, R., & Barnham, K. J. (2007). The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochimica et Biophysica Acta, 1768, 1976-1990. (Pubitemid 47125850)
49. Tamura, H., Kawakami, H., Kanamoto, T., Kato, T., Yokoyama, T., Sasaki, K., et al. (2006). High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. Journal of the Neurological Sciences, 246, 79-83. (Pubitemid 43815345)
50. Tanito, M., Minami, M., Akahori, M., Kaidzu, S., Takai, Y., Ohira, A., et al. (2008). LOXL1 variants in elderly Japanese patients with exfoliation syndrome/glaucoma, primary open-angle glaucoma, normal tension glaucoma, and cataract. Molecular vision, 14, 1898-1905.
51. Thorleifsson, G., Magnusson, K. P., Sulem, P., Walters, G. B., Gudbjartsson, D. F., Stefansson, H., et al. (2007). Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science (New York, N. Y), 317, 1397-1400. (Pubitemid 47417481)
52. Vanmechelen, E., Vanderstichele, H., Davidsson, P., Van Kerschaver, E., Van der Perre, B., Sjogren, M., et al. (2000). Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: A sandwich ELISA with a synthetic phosphopeptide for standardization. Neuroscience Letters, 285, 49-52. (Pubitemid 30224621)
53. Vickers, J. C., Craig, J. E., Stankovich, J., McCormack, G. H., West, A. K., Dickinson, J. L., et al. (2002). The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma. Molecular vision, 8, 389-393. (Pubitemid 36153629)
54. von Otter, M., Landgren, S., Nilsson, S., Zetterberg, M., Celojevic, D., Bergstrom, P., et al. (2010). Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract. Mechanisms of Ageing and Development, 131, 105-110.
55. Williams, S. E., Whigham, B. T., Liu, Y., Carmichael, T. R., Qin, X., Schmidt, S., et al. (2010). Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population. Molecular vision, 16, 705-712.
56. Yang, X., Zabriskie, N. A., Hau, V. S., Chen, H., Tong, Z., Gibbs, D., et al. (2008). Genetic association of LOXL1 gene variants and exfoliation glaucoma in a Utah cohort. Cell Cycle, 7, 521-524. (Pubitemid 351366482)
57. Zetterberg, H., Wahlund, L. O., & Blennow, K. (2003). Cerebrospinal fluid markers for prediction of Alzheimer's disease. Neuroscience Letters, 352, 67-69. (Pubitemid 37412328)
58. Zetterberg, M., Tasa, G., Palmer, M. S., Juronen, E., Teesalu, P., Blennow, K., et al. (2007). Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma. American Journal of Ophthalmology, 143, 1059-1060. (Pubitemid 46779037)